3 Drugs to Market in 2010 (Market Cap 7 Mio$) !!!!!!!!!!!!!!!!!!!!!!11

[BiotechMaster]

GET IN NOW BEFORE THE STOCK GETS DISCOVERED !!!!!!!!!!!!

Puramed (PMBS)

Market Cap: 7 Mio$
Price: 0,56 $

Shares Out : 12,6 M


Why Puramed Bioscience Inc. (PMBS.OB) Should Be On Your Radar


PuraMed Bioscience, Inc. is a pharmaceutical company focused on developing and marketing a line of new, non-prescription medicines. These products target major consumer health needs, including the treatment of headaches, insomnia, and general pain. The company aims launch its first retail products within six months, and then leverage that success to become a leader in the Over-the-Counter (OTC) medicine marketplace.

Although PuraMed Bioscience is entering into a competitive market, the company’s products promise to bring innovation to the industry, allowing for faster absorption into the blood stream, greater effectiveness, fewer side effects, and lower dosage requirements. The first three products the company plans to introduce include: LipiGesic M™ (for acute relief of migraine headaches), LipiGesic H™ (for acute relief of tension headaches) and LipiGesic PM™ (for insomnia).

PuraMed is already sufficiently funded via private funding and ready to move forward with the execution of its comprehensive business plan. Recently BrokerBank analyst Philip Wright, CFA initiated investment coverage of the company and has rated the company as a “speculative buy”. Wright praised the company for running on a lean basis by keeping salaries reasonable and office overhead costs extremely low.

The share structure of the stock is also attractive with only 7,929,246 shares of common stock outstanding as of last month. PuraMed is also a fully reporting company, meaning the company must be audited by a PCAOB registered public accounting firm and must comply with the requirements of Sarbanes-Oxley. These requirements allow for greater transparency and the ability to attract a larger investor audience, subsequently enhancing shareholder value and providing greater access to capital for further growth.

With a management team bringing more than 80 years of combined industry experience, a product line addressing major healthcare needs with many competitive advantages, and a well thought-out business plan, this company is well on its way to success in the multi-billion dollar OTC medicine market. Continue to watch this company as it strives to dramatically improve the quality of life for millions of Americans.

[Cosmic]

I did go back and look up that QGLY play, with the Cold-Eeze or whatever it was. Did get some action but you would have had to been in / out as the chart sezs.

So this is more a marketing type play to success more than anything else???

Any idea when the products acutally be available and the ads start??

I've put it on my watch list and will give a TA look daily. Watch for that turn up.

Thanks for the tip, tho I never have made a dime in bio, medical, pharm type stocks. I have a hard time relating to them and what is important. At least this one I have a foggy chance to understand. The low stock issues make for a screamer if you get it right.

[justin]

what is going on with cardium (cxm) even after a good financial report it is stil sluggish and begining to bother me.

[BiotechMaster]

Good news is coming .....

Puramed (PMBS.OB)

Market Cap: 10 Mio$
Price: 0,75 $

Shares Out : 12,6 M
Float : 2 M


http://www.otcstockreview.com/Files/...MBS_Review.pdf

[BiotechMaster]

Still a huge Opportunity here ....

A MUST READ !!
http://www.puramedbioscience.com/Pur...%201-13-10.ppt

[BiotechMaster]

This stock will move much higher very soon .. A big bargain at current level !!

PMBS.OB: Summary for PURAMED BIOSCIENCE- Yahoo! Finance


Strong Buy

[BiotechMaster]

RAALLLLYYYYYY HAS JUST BEGUN ..WE COULD SEE 2$ WITHIN 2 WEEKS !!!

GET IN NOW BEFORE THE STOCK GETS DISCOVERED . THIS IS A 10 BAGGER EASILY !!!!


PMBS JUMPS TO 1,19$ !!!!!!!!!!!!!!!!!!!


Puramed (PMBS.OB)

Market Cap: 8,9 Mio$
Price: 0,67 $

Shares Out : 12,6 M ( 8,6 M Shares held by Insider)
Float : 2,6 Million



PuraMed Bioscience, Inc. (PMBS.OB) Targets Two Market Opportunities


PuraMed Bioscience, Inc., a non-prescription pharmaceutical company, believes it has identified huge and largely untapped market opportunities, and has laid out a solid plan to capture them. The company, based in Schofield, Wisconsin, was established with two specific goals in mind, representing these two OTC (over-the-counter) product opportunities.

The first objective is to rapidly build a substantial and profitable business based upon three OTC products already developed by the company founders. The products, designed for headache and insomnia relief, are each unique in their own class, and collectively target a $2 billion American market.

LipiGesic MTM is a proprietary formulation created for the acute relief of migraine headaches within minutes. LipiGesic HTM is designed to dramatically increase the speed and levels of relief of tension headaches, effective at low doses and with the fewest potential side effects. LipiGesic PMTM is a new class of OTC sleep aid containing a proprietary blend of ingredients for the quick and natural relief of insomnia.

The second, longer term objective is to establish a leadership position in the highly fragmented OTC natural and alternative health remedy market by introducing a new kind of product line. By applying hard science to natural products, PuraMed believes it can deliver products providing better performance while having fewer side effects.

The company also believes their products will benefit from the kind of effective opportunity identification and marketing that is largely absent in the natural OTC market. Promising research in the field often goes overlooked for years by large pharmaceutical companies. Through the effective use of clinical trials in conjunction with carefully timed and aggressive marketing, PuraMed is convinced that it can better reach a major part of the OTC market.

The two founders of PuraMed, Russ Mitchell and Jim Higgins, both have extensive experience in the successful sale and distribution of new health products, with novel strategies that have proven highly effective over multiple applications. Through the use of outside production and other third party resources, they plan to rapidly build their position, and consider marketing to be key to the new company’s success.


About the Company

PuraMed was established to capture two unique opportunities. The first is to build a substantial and profitable business, rapidly, beginning with three products developed by its founders: LipiGesic™ M (for acute relief of migraine headaches), LipiGesic™ H(for acute relief of tension headaches) and PuraMed™ PM (for insomnia). Each of these is effective and addresses a very large OTC consumer market, collectively well over $2 billion in the U.S. Each product will be unique in its class .

[BiotechMaster]

PMBS will go over 5$ very very soon .Better get in before its too late ..

Huge Pipeline ..

LipiGesic™ M

LipiGesic™ M provides acute relief from migraine headaches, and contains the herbs feverfew and ginger as principal ingredients. PuraMed believes that its specific formulation of these herbs for its migraine remedy is unique and proprietary, providing relief from these severe headaches in minutes. The Company believes it will capture a material segment of the huge migraine headache remedy market. We believe that Americans spend in excess of $6 billion annually on headache pain relievers, and that over half of sufferers of migraine headaches rely exclusively on non-prescription medications.

We believe that at least 30 million Americans suffer from chronic migraine headaches with over 20 million of them having “severe” migraine conditions. Thus migraine headaches constitute a severe and disabling condition for millions of people. We further believe that the economic burden alone to the U.S. economy is in excess of $20 billion annually.

LipiGesic™ M is effective, available as a non-prescription remedy, without any known side effects, and affordable compared to more expensive migraine drugs based on prescription chemical formulations.

LipiGesic™ PM

LipiGesic™ PM is a new class of non-prescription sleep aid without any known side effects, and contains a proprietary blend of natural ingredients including Valerian, St. John’s Wort, and Chamomile. We believe that the proprietary blend of these ingredients provides an effective remedy for insomnia and other sleep disorders. The sleep aid market features products based primarily on chemical antihistamines.

Accordingly, the LipiGesic™ PM product provides a wide open market opportunity for an effective, natural alternative to prescription medications, which are somewhat addictive and often cause withdrawal symptoms and other side effects. We have priced LipiGesic™ PM as a premium sleep aid product, which provides us with a projected gross margin of approximately 80%. This large margin should leave us substantial room for ample introductory promotion, product allowances and other incentives conducive to achieving rapid market penetration.

Similar to the migraine remedy market, the market for sleep aid products represents a very large segment of the overall healthcare products marketplace. We believe that over half of all adults in the U.S. suffer from sleep disorders, and that many of them experience persistent insomnia. The National Center on Sleep Disorders has reported that there are as many as 70 million problem sleepers in the U.S. with many of them suffering from chronic sleep disorders. We believe that insomnia is second only to pain as a healthcare complaint.

Future LipiGesic™ Products

We have completed development of additional non-prescription products, which we intend to launch commercially over the next couple years after establishing a solid market for our initial two products. These other PuraMed products include:

LipiGesic™ H – provides relief for common tension headaches which afflict a majority of American adults from time to time. This remedy provides headache relief features a unique proprietary formulation of St. John’s Wort and common aspirin.

LipiGesic™ Smoker’s Pal – provides relief from the symptoms associated with nicotine withdrawal with the added benefit of an appetite suppressant.

LipiGesic™ RLS – provides relief of problematic leg cramps associated with Restless Leg Syndrome affecting a large segment of the population in the U.S.

LipiGesic™ GI – provides relief of symptoms associated with nighttime reflux disorders.

LipiGesic™ CS – provides fast relief for canker sore outbreaks.

[BiotechMaster]

Interview with PMBS CEO
PMBS CEO



More about PMBS ..

PuraMed BioScience (OTCBB:PMBS)

Summary

Now is an exciting time for PMBS and its shareholders. To date it has kept a relatively low profile, choosing to focus on building value for itself by developing its technology and brands rather than market visibility. As the Company rolls out new products and expands the awareness of its existing brands, we believe investors will certainly notice the stock. As a result, the price and trading volume of PMBS should increase as investors learn about this incredible opportunity.

With a management team that has "done this before" to the tune of a $70 million company, we believe sales of products introduced by PMBS will be very strong. With wide profit margins on the products sold by PMBS, in our opinion, shareholders will benefit from a higher stock price as revenues and profits increase.

Growth oriented investors should consider adding shares of PMBS to their portfolio at these levels. Once its products show up on the shelves of major retailers and the stock begins to be more widely followed by Wall Street, investors could see five to ten-fold returns.

[matx]

Hey Biotechmaster....its got only a few thousand average volume....and its on OTC
care to still promote it?